Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab.

Literature DB >> 26024733

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab.

Silvia Piantoni¹, Mirko Scarsi, Angela Tincani, Paolo Airò.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 26024733 DOI： 10.1007/s00296-015-3295-0

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

× No keyword cloud information.

5 in total

Review 1. The pathogenesis of rheumatoid arthritis.

Authors: Iain B McInnes; Georg Schett
Journal: N Engl J Med Date: 2011-12-08 Impact factor: 91.245

2. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.

Authors: S M Crowe; J B Carlin; K I Stewart; C R Lucas; J F Hoy
Journal: J Acquir Immune Defic Syndr (1988) Date: 1991

Review 3. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.

Authors: Britt Nakken; Ludvig A Munthe; Yrjö T Konttinen; Anna Klokk Sandberg; Zoltan Szekanecz; Philip Alex; Peter Szodoray
Journal: Autoimmun Rev Date: 2011-07-14 Impact factor: 9.754

4. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors: Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal: N Engl J Med Date: 2004-06-17 Impact factor: 91.245

5. Rituximab-induced T cell depletion in patients with rheumatoid arthritis: association with clinical response.

Authors: J Mélet; D Mulleman; P Goupille; B Ribourtout; H Watier; G Thibault
Journal: Arthritis Rheum Date: 2013-11

5 in total

8 in total

Review 1. A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors: Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal: Clin Rheumatol Date: 2019-08-01 Impact factor: 2.980

2. CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.

Authors: Amina Bensalem; Denis Mulleman; Gilles Thibault; Nicolas Azzopardi; Philippe Goupille; Gilles Paintaud; David Ternant
Journal: Br J Clin Pharmacol Date: 2019-11-22 Impact factor: 4.335

3. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

Authors: Duvuru Geetha; Sanjeev Sethi; An S De Vriese; Ulrich Specks; Cees G M Kallenberg; Noha Lim; Robert Spiera; E William St Clair; Peter A Merkel; Philip Seo; Paul A Monach; Nicola Lepori; Barri J Fessler; Carol A Langford; Gary S Hoffman; Rishi Sharma; John H Stone; Fernando C Fervenza
Journal: Am J Nephrol Date: 2017-09-08 Impact factor: 3.754

4. A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.

Authors: Martin H Stradner; Christian Dejaco; Kerstin Brickmann; Winfried B Graninger; Hans Peter Brezinschek
Journal: Arthritis Res Ther Date: 2016-08-24 Impact factor: 5.156

5. Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

Authors: Matthieu Lavielle; Denis Mulleman; Philippe Goupille; Clément Bahuaud; Hsueh Cheng Sung; Hervé Watier; Gilles Thibault
Journal: Arthritis Res Ther Date: 2016-10-28 Impact factor: 5.156